首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷內視鏡檢查設備

市場調查報告書

商品編碼

1304586

全球陰道鏡市場 - 2023-2030

Global Colposcopes Market - 2023-2030

出版日期: 2023年07月07日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概述

全球陰道鏡市場規模在2022年達到6億美元，預計到2030年將實現9億美元的強勁成長。在預測期內（2023-2030年），全球陰道鏡市場預計將呈現5.7%的複合年成長率。技術的不斷進步和對新型產品投資的不斷成長推動了陰道鏡市場需求的發展趨勢。

陰道鏡市場包括確定是否存在宮頸癌或外陰癌等其他疾病的檢測。技術先進的新產品的推出以及宮頸癌患者的增加是推動全球陰道鏡市場發展的主要因素。

陰道鏡的市場範圍包括宮頸癌篩查、體格檢查及其他應用，這增加了陰道鏡的市場佔有率。全球陰道鏡市場正在不斷擴大，其原因包括不斷增加的研究和開發，以及各國即將批准的新型產品，這也為陰道鏡市場的成長創造了積極的前景。

市場動態

越來越多的女性採用陰道鏡進行細胞學管理，推動了癌症診斷市場的成長。

通過細胞學檢查可確定哪些婦女更有可能罹患浸潤性癌症或高級別宮頸癌前病變。對於細胞學異常的婦女，陰道鏡等診斷性檢查對於定位異常、確診和確定最佳治療方案至關重要。

"即看即治"策略為陰道鏡懷疑有高級別病變的婦女提供治療，而無需等待組織學確診。事實證明，這一策略可降低隨訪損失率，並有效利用偏遠地區有限的醫療資源。

在一項基於印度社區的研究中，訓練有素的護士對VIA陽性的婦女進行陰道鏡檢查，如果發現異常病變，當天就為婦女提供冷凍治療（前提是病變符合消融治療的要求）。 CIN1（宮頸上皮內瘤變）婦女的治愈率為81.4%；CIN2為71.4%；CIN3為68.0%。近75%符合條件的婦女在同一次就診時接受了治療。

主要公司的研發和新產品發佈為製造商創造了有利的機會

由人工智慧（AI）驅動的數位移動陰道鏡為目前的宮頸癌標準治療提供了一種篩查選擇，有望大大提高準確性和速度- 提供結果的時間不到一分鐘。 MobileODT公司（以色列特拉維夫）的EVAPro引進了宮頸癌篩查的最新技術發展，增強了患者與醫生之間的互動。

最新的EVAPro數位陰道鏡輕巧攜帶，具有出色的圖像品質和尖端的軟體功能。醫生可以利用這一特殊組合記錄、追踪和存儲整個治療過程。 EVAPro圖像的自發光特性使圖像捕捉更加清晰。綠色濾光片用於圖像分析，以評估異常動脈和其他地標或病變。在使用自動對焦時，每張圖像都會對宮頸的存在、照明、位置和焦點進行評估。

圖像品質可通過圖像引導技術和機器學習（ML）進行評估，告知醫生圖像是否適合目測檢查或陰道鏡檢查。 EVAPro使用機器學習（ML）和人工智慧（AI）進行廣泛的宮頸癌篩查。在照護端，VisualCheck是基於人工智慧的電腦輔助診斷工具，可使用EVAPro數位陰道鏡評估發育不良的風險。

結腸鏡的替代品將阻礙市場成長。

全球對陰道鏡的需求正受到結腸鏡替代品可用性等問題的阻礙。在早期研究中，宮頸數位攝影（CDP）曾被提議作為宮頸篩查的替代技術。

CDP是一種很有前途的陰道鏡替代技術。隨著進一步的研究，CDP在臨床實踐中的總體效用可能會得到更好的理解。陰道鏡檢查或宮頸攝影的線上表格也可能有用。此外，使用智慧手機鏡頭也可替代陰道鏡檢查。

COVID-19 影響分析

COVID-19疫情爆發和全球封鎖影響了各行業公司的財務穩定性。因此，美國食品和藥物管理局(FDA)發布了COVID-19衛生緊急狀態期間的指導方針，其中包括協助申辦者和研究人員、確保試驗參與者安全、遵循良好臨床實踐(GCP)和降低試驗完整性風險的一般注意事項。

俄烏戰爭影響分析

據估計，俄烏衝突對全球陰道鏡市場的影響較小，因為該地區的主要市場參與者較少。然而，原料進出口的影響預計在預測期內對全球陰道鏡市場成長的影響不大。

Market Overview

The global colposcopes market reached US$ 0.6 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 0.9 billion by 2030. The global colposcopes market is expected to exhibit a CAGR of 5.7% during the forecast period (2023-2030). The increasing technological advancements and the growing investments for novel products are driving up demand for colposcopes market trends.

The market for colposcopes includes tests that establish the existence of the cervical cancer or other diseases such as vulvar cancer and more. The launch of new technologically advanced products, and an increase in patients with cervical cancer are the main factors propelling the global market for colposcopes.

The colposcopes market scope comprises application as cervical cancer screening, physical examinations and others, which has increased the colposcopes market share. The global market for colposcopes is expanding as a result of factors including the increasing research and development and their upcoming novel product approvals across countries are also creating a positive outlook for the colposcopes market growth.

Market Dynamics

Increasing Adoption of Colposcopes for Women Cytology Management Drive the Growth of the Cancer Diagnostic market

Women who are more likely to have invasive cancer or high-grade cervical premalignant lesions are identified by cytology. For women with abnormal cytology, a diagnostic test such a colposcopy is essential for localizing the abnormality, confirming the diagnosis, and determining the best course of treatment.

The "see and treat" strategy offers treatment to women who have high-grade lesions that are colposcopically suspected without waiting for histology confirmation. This strategy has been demonstrated to reduce the rates of follow-up loss and to effectively use the limited medical resources available in remote places.

In an Indian community-based study, trained nurses performed colposcopies on VIA-positive women, and if abnormal lesions were found, the women were offered cryotherapy treatment the same day (provided the lesion met the requirements for treatment by ablation). The cure results were 81.4% for women having CIN 1 (Cervical Intra-epithelial Neoplasia); 71.4% for CIN 2; and 68.0% for CIN 3. Almost 75 percent of eligible women accepted therapy at the same visit.

Rising Research and Development and Novel Product Launch by Key Companies creates Lucrative Opportunities for Manufacturers

A digital mobile colposcope powered by artificial intelligence (AI) offers a screening option to the current standard treatment for cervical cancer, promising greatly improved accuracy and speed-delivery of results takes less than a minute. The EVAPro from MobileODT (Tel Aviv, Israel) introduces the most recent technological development in cervical cancer screening, enhancing the patient-physician interaction.

The latest EVAPro digital colposcope is portable and light, with outstanding image quality and cutting-edge software capabilities. Doctors can record, track, and store the full course of treatment using this special combination. The self-illuminating nature of EVAPro pictures makes for crisper image capturing. A green filter is used in image analysis to assess aberrant arteries and other landmarks or lesions. The existence, illumination, location, and focus of the cervix are all evaluated for each image while using autofocus.

Image quality can be assessed using image-guided technology and machine learning (ML), informing the doctor if the image would be appropriate for visual examination or colposcopic review. EVAPro uses machine learning (ML) and artificial intelligence (AI) for extensive cervical cancer screening. At the point of care, VisualCheck, based on artificial intelligence, computer-aided diagnostic tool, assesses the risk of dysplasia using the EVAPro digital colposcope.

Availability of Alternatives for Colonoscopes will Hamper the Growth of the Market.

Global demand for colposcopes is being restrained by issues like the availability of alternatives for colonoscopes. In earlier investigations, cervical digital photography (CDP) was previously proposed as an alternate cervical screening technique.

A promising substitute for colposcopy is CDP. The overall usefulness of CDP in clinical practice may be better understood with further study. Online forms for colposcopy or cervical photography may also be useful. Additionally, using a smartphone camera could be a useful substitute for colposcopy.

COVID-19 Impact Analysis

The financial stability of companies across all industries has been impacted by the COVID-19 outbreak and the global lockdown. As a result, the U.S. Food and Drug Administration (FDA) released guidelines for the duration of the COVID-19 health emergency that include general considerations to assist sponsors and researchers, ensure trial participants' safety, follow good clinical practice (GCP), and reduce risks to trial integrity.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a low impact on the global colposcopes market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global colposcopes market growth over the forecast period.

Segment Analysis

The global colposcopes market is segmented based on type, product type, technology, application, end user and region.

Cervical Cancer Screening from Application Segment Accounts for 56.4% of Market Share Owing to High Advantages

One kind of cervical cancer test is a colposcopy. It is a test to examine the cervix more closely. The cervix is the vaginal opening into the womb. If a cervical screening reveals cell alterations brought on by specific forms of human papillomavirus (HPV), a colposcopy is frequently performed.

The procedure of screening allows for the early diagnosis of diseases. For those who have a cervix, screening for cervical cancer is an essential component of regular medical care. Finding precancerous alterations in cervical cells, which can be treated to stop cervical cancer from growing, is the aim of screening for the disease. During cervical screenings, cancer can occasionally be discovered. Usually, it is simpler to treat cervical cancer in its early stages.

Cervical cancer cells may develop from these altered cells. Colposcopy is still the preferred procedure in high-resource settings following a positive cervical cytology or human papillomavirus (HPV) test result. The quantity and location of biopsies, as well as the training and experience of the colposcopists, all have a significant impact on how well colposcopy can guide treatment.

Geographical Analysis

North America Accounted for Approximately 39.5% of the Market Share Owing to the Strong Presence of Major Players and the Advancements in Cancer Diagnostics

Manufacturers have chances to expand their operations in this region because of the rising demand for colposcopes for advancements in North America. The area has many producers and suppliers, and its rapid economic development has raised industrial production of colposcopes, which has increased the demand.

There are many manufacturers and suppliers in North America, and as a result of the region's rapid economic growth, industrial production has expanded, feeding the desire for research and development of novel products.

As new technologies for research and development are developed, the market will expand. Rising technological developments, governmental approvals, and the introduction of new products all contribute to growth. People are becoming more aware of novel products and technologies, leading to the expansion of the market in this region. These factors are responsible for dominance of North America.

Competitive Landscape

The major global players in the colposcopes market include: Olympus Corporation, CooperSurgical Inc., McKesson Medical-Surgical Inc., DYSIS Medical Inc., Gynex Corporation, Ecleris, Karl Kaps GmbH & Co. KG, Medgyn Products Inc., Delmont imaging and Seiler Instrument Inc. among others.

Why Purchase the Report?

To visualize the global colposcopes market segmentation based on type, product type, portability, application, end user and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of colposcopes market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global colposcopes market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Product Type
3.3. Snippet by Portability
3.4. Snippet by Application
3.5. Snippet by End User
3.6. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Adoption of Colposcopes for Women Cytology Management
  - 4.1.1.2. Rising Incidence of Cervical Cancer
- 4.1.2. Restraints
  - 4.1.2.1. Availability of Alternatives for Colposcopes
- 4.1.3. Opportunity
  - 4.1.3.1. Rising Research and Development and Novel Product Launch
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 7.1.2. Market Attractiveness Index, By Product
7.2. Optical Colposcope *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Digital Colposcope

8. By Product Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 8.1.2. Market Attractiveness Index, By Product Type
8.2. Video *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Binocular

9. By Portability

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
- 9.1.2. Market Attractiveness Index, By Portability
9.2. Trolley-mounted *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Handheld

10. By Application

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.1.2. Market Attractiveness Index, By Application
10.2. Cervical Cancer Screening *
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Physical Examinations
10.4. Others

11. By End User

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.1.2. Market Attractiveness Index, By End User
11.2. Hospitals *
- 11.2.1. Introduction
- 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Diagnostic Laboratories
11.4. Specialty Clinics
11.5. Others

12. By Region

12.1. Introduction
- 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 12.1.2. Market Attractiveness Index, By Region
12.2. North America
- 12.2.1. Introduction
- 12.2.2. Key Region-Specific Dynamics
- 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
- 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.2.8.1. U.S.
  - 12.2.8.2. Canada
  - 12.2.8.3. Mexico
12.3. Europe
- 12.3.1. Introduction
- 12.3.2. Key Region-Specific Dynamics
- 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
- 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.3.8.1. Germany
  - 12.3.8.2. U.K.
  - 12.3.8.3. France
  - 12.3.8.4. Spain
  - 12.3.8.5. Italy
  - 12.3.8.6. Rest of Europe
12.4. South America
- 12.4.1. Introduction
- 12.4.2. Key Region-Specific Dynamics
- 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 12.4.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 12.4.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
- 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.4.6.1. Brazil
  - 12.4.6.2. Argentina
  - 12.4.6.3. Rest of South America
12.5. Asia-Pacific
- 12.5.1. Introduction
- 12.5.2. Key Region-Specific Dynamics
- 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
- 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.5.8.1. China
  - 12.5.8.2. India
  - 12.5.8.3. Japan

Australia

12.5.8.4. Rest of Asia-Pacific

12.6. Middle East and Africa
- 12.6.1. Introduction
- 12.6.2. Key Region-Specific Dynamics
- 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
- 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

13. Competitive Landscape

13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis

14. Company Profiles

14.1. Olympus Corporation *
- 14.1.1. Company Overview
- 14.1.2. Product Portfolio and Description
- 14.1.3. Financial Overview
- 14.1.4. Key Developments
14.2. CooperSurgical Inc.
14.3. McKesson Medical-Surgical Inc.
14.4. DYSIS Medical Inc.
14.5. Gynex Corporation
14.6. Ecleris
14.7. Karl Kaps GmbH & Co. KG
14.8. Medgyn Products Inc.
14.9. Delmont imaging
14.10. Seiler Instrument Inc.

LIST NOT EXHAUSTIVE